| Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols PS Tofts, G Brix, DL Buckley, JL Evelhoch, E Henderson, MV Knopp, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 1999 | 3941 | 1999 |
| Imaging biomarker roadmap for cancer studies JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ... Nature reviews Clinical oncology 14 (3), 169-186, 2017 | 1112 | 2017 |
| The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations MO Leach, KM Brindle, JL Evelhoch, JR Griffiths, MR Horsman, A Jackson, ... British journal of cancer 92 (9), 1599-1610, 2005 | 618 | 2005 |
| Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study WG Negendank, R Sauter, TR Brown, JL Evelhoch, A Falini, ED Gotsis, ... Journal of neurosurgery 84 (3), 449-458, 1996 | 501 | 1996 |
| Key factors in the acquisition of contrast kinetic data for oncology JL Evelhoch Journal of Magnetic Resonance Imaging: An Official Journal of the …, 1999 | 471 | 1999 |
| Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with … G Liu, HS Rugo, G Wilding, TM McShane, JL Evelhoch, C Ng, E Jackson, ... Journal of clinical oncology 23 (24), 5464-5473, 2005 | 315 | 2005 |
| MR imaging of tumor microcirculation: promise for the new millenium JS Taylor, PS Tofts, R Port, JL Evelhoch, M Knopp, WE Reddick, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 1999 | 288 | 1999 |
| Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors RS Herbst, D Hong, L Chap, R Kurzrock, E Jackson, JM Silverman, ... Journal of Clinical Oncology 27 (21), 3557-3565, 2009 | 285 | 2009 |
| Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium LM Resnick, D Militianu, AJ Cunnings, JG Pipe, JL Evelhoch, RL Soulen Hypertension 30 (3), 654-659, 1997 | 275 | 1997 |
| Preclinical characterization of 18F-MK-6240, a promising PET tracer for in vivo quantification of human neurofibrillary tangles ED Hostetler, AM Walji, Z Zeng, P Miller, I Bennacef, C Salinas, ... Journal of nuclear medicine 57 (10), 1599-1606, 2016 | 262 | 2016 |
| Accuracy and precision of quantitative assessment of cartilage morphology by magnetic resonance imaging at 3.0 T F Eckstein, HC Charles, RJ Buck, VB Kraus, AE Remmers, M Hudelmaier, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2005 | 252 | 2005 |
| Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo M Zhao, JG Pipe, J Bonnett, JL Evelhoch British journal of cancer 73 (1), 61-64, 1996 | 245 | 1996 |
| Quantitative magnetic resonance imaging phantoms: a review and the need for a system phantom KE Keenan, M Ainslie, AJ Barker, MA Boss, KM Cecil, C Charles, ... Magnetic resonance in medicine 79 (1), 48-61, 2018 | 182 | 2018 |
| Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126 JL Evelhoch, PM LoRusso, Z He, Z DelProposto, L Polin, TH Corbett, ... Clinical Cancer Research 10 (11), 3650-3657, 2004 | 182 | 2004 |
| Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for … AM Walji, ED Hostetler, H Selnick, Z Zeng, P Miller, I Bennacef, C Salinas, ... Journal of medicinal chemistry 59 (10), 4778-4789, 2016 | 175 | 2016 |
| Applications of magnetic resonance in model systems: tumor biology and physiology RJ Gillies, ZM Bhujwalla, J Evelhoch, M Garwood, M Neema, ... Neoplasia 2 (1-2), 139-151, 2000 | 162 | 2000 |
| Applications of magnetic resonance in model systems: cancer therapeutics JL Evelhoch, RJ Gillies, GS Karczmar, JA Koutcher, RJ Maxwell, ... Neoplasia 2 (1-2), 152-165, 2000 | 162 | 2000 |
| Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials MO Leach, KM Brindle, JL Evelhoch, JR Griffiths, MR Horsman, A Jackson, ... The British journal of radiology 76 (suppl_1), S87-S91, 2003 | 148 | 2003 |
| In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C … ED Hostetler, AD Joshi, S Sanabria-Bohórquez, H Fan, Z Zeng, M Purcell, ... Journal of Pharmacology and Experimental Therapeutics 347 (2), 478-486, 2013 | 137 | 2013 |
| Signal-to-noise optimization and observed volume localization with circular surface coils JL Evelhoch, MG Crowley, JJH Ackerman Journal of Magnetic Resonance (1969) 56 (1), 110-124, 1984 | 132 | 1984 |
